News | April 02, 2009

VOLCANO Integrates FFR on All Major Cardiovascular Angiography Systems

April 2, 2009 - Volcano Corp. this week at ACC 2009 announced the availability of its integrated fractional flow reserve (FFR) technology on all major cardiovascular X-ray systems.

Interest in the use of FFR, a guidewire-based technology that helps assess a lesion’s severity based on the amount of blood flow through the lesion, has increased significantly since the release of the multi-center randomized FAME (FFR vs. Angiography for Multivessel Evaluation) data in late 2008 and publication in the New England Journal of Medicine in January 2009. FAME demonstrated FFR-guidance in routine multi-vessel PCI resulted in clinically-superior outcomes and reduced the composite of death, documented myocardial infarction, and repeat revascularization by 30 percent at one year. The study also demonstrated that these improved clinical outcomes were complemented by significantly reduced cost to the hospitals involved in the trial.

Volcano’s integrated FFR technology can be purchased as part of its s5i system, offering clinicians access to IVUS and FFR at the patient bedside. Volcano has relationships with each of the major cardiovascular X-ray companies to facilitate the installation of the s5i with integrated FFR in any cath lab.

Volcano said it experienced an FFR growth of 36 percent in Q4 2008 versus Q4 2007 and that physicians are increasingly relying on FFR to help guide PCI procedures.

Volcano's integrated s5i was on display at the 2009 ACC meeting in Orlando at the company’s booth as well as in the booths of GE, Philips, Siemens and Toshiba.

For more information: www.volcanocorp.com

Related Content

In June 2019, Medis received clearance from the U.S. Food and Drug Administration for its QAngio XA 3D technology (QFR). The FFR-angio technology can show the FFR readings in a 3-D image and overlaid on a fluoro image.

In June 2019, Medis received clearance from the U.S. Food and Drug Administration for its QAngio XA 3D technology (QFR). The FFR-angio technology can show the FFR readings in a 3-D image and overlaid on a fluoro image. 

Feature | FFR Technologies | August 05, 2019 | Dave Fornell and Greg Freiherr
New technologies have been developed that may replace the traditional pressure wires and adenosine to assess the...
First Prospective Registry Confirms FFR Impacts CAD Treatment Plans
News | FFR Technologies | June 17, 2019
A prospective, multicenter, multinational study examines how fractional flow reserve (FFR) can impact treatment plans...
One in Four Patients Have Residual Ischemia Following PCI
News | FFR Technologies | March 20, 2019
At the American College of Cardiology’s (ACC) annual meeting, March 16-18 in New Orleans, Philips announced the results...
HeartFlow Analysis Successfully Stratifies Heart Disease Patients at One Year
News | FFR Technologies | March 19, 2019
Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables...
Abbott's Resting Full-cycle Ratio (RFR) intravascular diagnostic test is a newer type of fractional flow reserve (FFR) physiologic assessment. RFR is used to help identify significant narrowings of coronary arteries to determine the need for a stent or if a patient can be treated medically. Abbott FFR.

Abbott's Resting Full-cycle Ratio (RFR) intravascular diagnostic test is a newer type of fractional flow reserve (FFR) physiologic assessment. RFR is used to help identify significant narrowings of coronary arteries to determine the need for a stent or if a patient can be treated medically. 

Technology | FFR Technologies | March 06, 2019
March 5, 2019 –  The U.S.
CathWorks FFRangio System Receives U.S. FDA Clearance
Technology | FFR Technologies | December 21, 2018
CathWorks announced that its FFRangio System received U.S. Food  and Drug Administration (FDA) 510(k) clearance. The...
The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks FFRangio angiography imaging derived fractional flow reserve (FFR-angio) technology matched the performance of wire-based FFR measurements. #TCT2018

The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks FFRangio angiography imaging derived fractional flow reserve (FFR-angio) technology matched the performance of wire-based FFR measurements.

News | FFR Technologies | October 04, 2018
October 4, 2018 — The late-breaking FAST-FFR Trial demonstrated that the sensitivity and specificity of the CathWorks
SCAI and the European Society of Cardiology recently added iFR to their guidelines.

An illustration of Philip’s iFR technology, showing the iFR pressure readings and a fusion angio image indicating pressure drops in the vessel during wire pull back. SCAI and the European Society of Cardiology recently added iFR to their guidelines.

Feature | FFR Technologies | September 05, 2018 | Dave Fornell, Editor
The use of invasive, pressure wire-based fractional flow reserve (FFR) in the cath lab is now considered the gold sta
European Society of Cardiology Incorporates iFR Technology Into Updated Revascularization Guidelines
News | FFR Technologies | August 29, 2018
Philips announced that the European Society of Cardiology (ESC) has incorporated instantaneous wave-free ratio (iFR)...
iFR reference numbers posted for new users in the cath lab at Northwestern Medicine's Central DuPage Hospital in Winfield, Ill.
News | FFR Technologies | July 26, 2018
July 26, 2018 — The Society of Cardiac Angiography and Interventions (SCAI) released a focused update expert consensu
Overlay Init